This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Petr Novak
Introduction
Petr Novak is a notable inventor based in Uvaly, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that aid in the production of important drug intermediates. His work is particularly relevant in the fight against tuberculosis.
Latest Patents
Petr Novak holds a patent for a process titled "Process for production of 2-chloro-4-nitroimidazole derivatives." This innovative process provides an improved method for preparing 2-chloro-4-nitroimidazole derivatives, which serve as useful intermediates in the preparation of an anti-tuberculosis drug. The process involves chlorinating nitroimidazoles using a chlorinating agent and an activating agent to yield the desired derivatives.
Career Highlights
Petr Novak is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to contribute to pharmaceutical innovations. His expertise in chemical processes has positioned him as a valuable asset in the development of new treatments.
Collaborations
Petr has collaborated with notable colleagues such as Jiri Tauchman and Jan Koci. Their combined efforts in research and development have further advanced the field of pharmaceutical sciences.
Conclusion
Petr Novak's contributions to the field of pharmaceuticals, particularly through his patent on the production of 2-chloro-4-nitroimidazole derivatives, highlight his role as an important inventor in the fight against tuberculosis. His work continues to inspire advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
